Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Amortizatization of Intangibles: 2022-2024

Historic Amortizatization of Intangibles for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $1.5 million.

  • Orchestra BioMed Holdings' Amortizatization of Intangibles fell 45.51% to $194,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $722,000, marking a year-over-year decrease of 62.16%. This contributed to the annual value of $1.5 million for FY2024, which is 60.70% down from last year.
  • Orchestra BioMed Holdings' Amortizatization of Intangibles amounted to $1.5 million in FY2024, which was down 60.70% from $3.8 million recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Amortizatization of Intangibles ranged from a high of $3.8 million in FY2023 and a low of $600,000 during FY2022.
  • Its 3-year average for Amortizatization of Intangibles is $2.0 million, with a median of $1.5 million in 2024.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first surged by 536.50% in 2023, then slumped by 60.70% in 2024.
  • Over the past 3 years, Orchestra BioMed Holdings' Amortizatization of Intangibles (Yearly) stood at $600,000 in 2022, then soared by 536.50% to $3.8 million in 2023, then slumped by 60.70% to $1.5 million in 2024.